Kochi, Jun 17 (PTI) A 51-year-old man, who was battling for life after being infected by coronavirus has recovered after undergoing convalescent plasma therapy at a government hospital in Thrissur, in a first such instance in Kerala using the experimental medical technique.

The beneficiary, who had been on ventilator for almost a week was taken off the support after a team of doctors administered the plasma of a person cured of the disease.

Also Read | Jammu And Kashmir | Staff Building Belonging to Indian Army Converted Into COVID Care Centre in Srinagar: Live Breaking News Headlines & Coronavirus Updates, June 17, 2020.

The man is now recuperating in the ICU, doctors said. The therapy involves separation of anti bodies from a person cured of coronavirus and its subsequent infusion into the COVID-19 patient in a critical condition. Performed as a medical emergency, the technique was used at the Government Medical College (GMC) in Thrissur. The benefactor was a Delhi-returned Malayali.

He tested positive for COVID-19 on June 6 and faced acute respiratory complications five days later, warranting the use of a ventilator.

Also Read | Indian Army Salutes the Supreme Sacrifice of Its Martyred Soldiers at Galwan in Ladakh, Says 'Their Sacrifices Will Not Go in Vain'.

On June 11 night, the patient underwent the convalescent plasma collection therapy that lasted till day break. "The procedure requires volunteers who have recovered from COVID-19 and are above the age of 18.

They can donate plasma, the yellowish liquid component of the blood, between the first and fourth months after cure," said M A Andrews, Principal of GMC in a statement issued by National Health Mission's Arogya Keralam. The therapy has proven its potential and given the COVID-19 patient a fresh lease of life, the doctor said. Convalescent plasma therapy relies on an apparatus called apheresis that separates the plasma from the donor's blood.

Unlike the usual blood donation, the remainder here returns to the donor's circulation. "In one go, we take 400 grams of plasma. And transfuse it into the COVID-19 patient in two phases of 200 grams each," Andrews said. "The therapy has absolutely no side effects," he added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)